نتائج البحث

Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors—protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial)

• Authors : Al-Ozairi, Ebaa¹ (AUTHOR); Narula, Kavita² (AUTHOR) ; Miras, Alexander D.^2,3 (AUTHOR)

• Source: Trials. 2/16/2024, Vol. 25 Issue 1, p1-14. 14p.

تفاصيل العنوان

Effects of finerenone and glucagon-like peptide 1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus: a systematic review and meta-analysis.

• Authors : Gu, Xia¹ (AUTHOR); Jiang, Shimin² (AUTHOR) ; Yang, Yue² (AUTHOR)

• Source: Diabetology & Metabolic Syndrome. 1/11/2024, Vol. 16, p1-12. 12p.

تفاصيل العنوان

Influence of postruminal casein infusion and exogenous glucagon-like peptide 2 administration on the jejunal mucosal transcriptome in cattle.

• Authors : Trotta RJ; Department of Animal and Food Sciences, University of Kentucky, Lexington, Kentucky, United States of America.; Swanson KC

Subjects: Glucagon-Like Peptide 2*/Glucagon-Like Peptide 2*/Glucagon-Like Peptide 2*/administration & dosage ; Glucagon-Like Peptide 2*/Glucagon-Like Peptide 2*/Glucagon-Like Peptide 2*/pharmacology ; Jejunum*/Jejunum*/Jejunum*/metabolism

• Source: PloS one [PLoS One] 2024 Aug 15; Vol. 19 (8), pp. e0308983. Date of Electronic Publication: 2024 Aug 15 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature.

• Authors : Chrysavgis, Lampros G.¹ (AUTHOR) ; Kazanas, Spyridon¹ (AUTHOR) ; Bafa, Konstantina¹ (AUTHOR)

Subjects: *GLUCAGON-like peptide 1; *INSULIN; *DISEASE nomenclature

• Source: International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 7, p3832. 28p.

تفاصيل العنوان

Impact of Glucagon-Like Peptide 1 Agonist Deprescription in Type 2 Diabetes in a Real-World Setting: A Propensity Score Matched Cohort Study.

• Authors : McKenzie, Amy L.¹ (AUTHOR); Athinarayanan, Shaminie J.¹ (AUTHOR)

• Source: Diabetes Therapy. Apr2024, Vol. 15 Issue 4, p843-853. 11p.

تفاصيل العنوان

Potential Role of Phytochemicals as Glucagon-like Peptide 1 Receptor (GLP-1R) Agonists in the Treatment of Diabetes Mellitus.

• Authors : Abiola, Julianah Ore^1,2,3 (AUTHOR) ; Oluyemi, Ayoola Abidemi³ (AUTHOR); Idowu, Olajumoke Tolulope⁴ (AUTHOR)

• Source: Pharmaceuticals (14248247). Jun2024, Vol. 17 Issue 6, p736. 22p.

تفاصيل العنوان

Impact of Glucagon-Like Peptide 1 Receptor Agonists on Biochemical Markers of the Initiation of Atherosclerotic Process.

• Authors : Hachuła, Marcin¹ (AUTHOR) ; Kosowski, Michał¹ (AUTHOR) ; Ryl, Sabina² (AUTHOR)

Subjects: *GLUCAGON-like peptide 1; *BIOMARKERS; *PEPTIDE receptors

• Source: International Journal of Molecular Sciences. Feb2024, Vol. 25 Issue 3, p1854. 12p.

تفاصيل العنوان

Testing for association between exonic glucagon-like peptide 1 receptor mutation with physical and brain health traits in UK Biobank

• Authors : Ward, J; Lyall, LM; Strawbridge, RJ

Subjects: Medicin och hälsovetenskap

• Source: Diabetes, obesity & metabolism. 25(2):623-627

تفاصيل العنوان

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update.

• Authors : Jakubowska, Agnieszka¹; le Roux, Carel W.²; Viljoen, Adie¹

• Source: Endocrinology & Metabolism. Feb2024, Vol. 39 Issue 1, p12-22. 11p.

تفاصيل العنوان

Serum Ghrelin and Glucagon-like Peptide 1 Levels in Children with Prader-Willi and Bardet-Biedl Syndromes

• Authors : Türkkahraman D; University of Health Sciences Turkey, Antalya Training and Research Hospital, Clinic of Pediatric Endocrinology, Antalya, Turkey; Tekin S

Subjects: Ghrelin*/Ghrelin*/Ghrelin*/blood ; Prader-Willi Syndrome*/Prader-Willi Syndrome*/Prader-Willi Syndrome*/blood ; Glucagon-Like Peptide 1*/Glucagon-Like Peptide 1*/Glucagon-Like Peptide 1*/blood

• Source: Journal of clinical research in pediatric endocrinology [J Clin Res Pediatr Endocrinol] 2024 May 31; Vol. 16 (2), pp. 146-150. Date of Electronic Publication: 2023 Dec 15.Publisher: Galenos Yayınevi Country of Publication: Turkey NLM ID: 101519456 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان